AI assistant
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2015
May 6, 2015
32163_dirs_2015-05-06_193918dc-fc44-46f1-b3e5-8aba3ec95c7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2015-05-06
Reporting Person: Heron Patrick J (Director, 10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Convertible Preferred Stock | $ | Common Stock (582490) | Indirect | ||
| Series B Convertible Preferred Stock | $ | Common Stock (222231) | Indirect | ||
| Series C Convertible Preferred Stock | $ | Common Stock (392113) | Indirect | ||
| Series D Convertible Preferred Stock | $ | Common Stock (532764) | Indirect |
Footnotes
F1: All series of Convertible Preferred Stock will automatically convert into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis immediately prior to the closing of the initial public offering and have no expiration date.
F2: The shares are held by Frazier Healthcare VI, L.P. The general partner of Frazier Healthcare VI, L.P. is FHM VI, L.P., a limited partnership, the general partner of which is FHM VI, LLC. The members of FHM VI, LLC are Dr. Nathan Every, Alan Frazier, Nader Naini, Patrick Heron, and Dr. James Topper. These individuals share voting and investment power over the shares held by Frazier Healthcare VI, L.P. Mr. Heron disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.